Forte Biosciences, Inc. (FBRX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2014: -$70.44M2015: -$92.33M2016: -$124.42M2017: $71.08M2018: -$736.0K2019: -$4.77M2020: $58.98M2021: $41.55M2022: $38.82M2023: $35.31M2024: $52.48M2025: $60.99M$60.99M
2014Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$60.99M+16.2%
2024$52.48M+48.6%
2023$35.31M-9.0%
2022$38.82M-6.6%
2021$41.55M-29.6%
2020$58.98M+1336.7%
2019-$4.77M-548.0%
2018-$736.0K-101.0%
2017$71.08M+157.1%
2016-$124.42M-34.8%
2015-$92.33M-31.1%
2014-$70.44M